Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

The over-the-counter medicine business is proving to be a lucrative one. And it’s one that is doing well in the current ...

Palantir may face tough competition in the software space from this AI titan that made its name selling AI hardware.

UnitedHealth (UNH) is a top pick for 2024, with a strong operating plan and valuation. We anticipate significant upside. See ...

CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.

Prof. Mark Hoogendoorn, Co-CEO and Co-Founder PersonalAIze: "The strategic partnership between PersonalAIze and Cube has the potential to provide a transformative leap in healthcare diagnostics, ...

A probable rate cut has provided hope for the economy. Despite that, the impact on financial markets and stocks remains ...

QHSLab is proud to announce that two key abstracts have been accepted for presentation at the American College of Allergy, Asthma, and Immunology (ACAAI) conference in Boston next month. These ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sean Snaith of the Institute for Economic Forecasting at UCF believes the Fed might want to get more data before cutting ...

The size of the Federal Reserve’s highly anticipated interest-rate cut this week is less relevant for equities than the ...